| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 45.041 | 27 |
| GSM780708 | Untreated after 4 days (C2_1) | 44.2111 | 23 |
| GSM780709 | Untreated after 4 days (C3_1) | 46.8797 | 36 |
| GSM780719 | Untreated after 4 days (C1_2) | 43.7593 | 21 |
| GSM780720 | Untreated after 4 days (C2_2) | 48.666 | 44 |
| GSM780721 | Untreated after 4 days (C3_2) | 46.9003 | 36 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 48.3385 | 42 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 42.9047 | 17 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 41.38 | 11 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 47.224 | 38 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 52.6188 | 55 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 46.039 | 32 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 47.9149 | 41 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 42.2722 | 14 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 41.2978 | 10 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 40.7549 | 9 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 48.1416 | 42 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 49.1713 | 46 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 41.3708 | 11 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 45.8332 | 31 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 45.7848 | 31 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 45.1626 | 28 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 47.2482 | 38 |